Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
Clinical trial NCT03348904 · TERMINATED
Trial details
- NCT number
- NCT03348904
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-27
- Primary completion
- 2018-05-22
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.